GIM
VCEL icon

Glenmede Investment Management’s Vericel Corp VCEL Stock Holding History

Glenmede Investment Management’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$403K Sell
12,812
-419
-3% -$15K ﹤0.01% 1016
2025
Q2 		$563K Buy
+13,231
New +$550K ﹤0.01% 883

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Glenmede Investment Management's VCEL Position: Q3 2025 in Review

Glenmede Investment Management reduced its Vericel Corp (VCEL) stake by 3.2% in Q3 2025, selling an estimated $15K and leaving 12,812 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Glenmede Investment Management first reported a position in VCEL in Q2 2025 and has held it in 2 quarters since. The position peaked at $563K in Q2 2025. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

  • Glenmede Investment Management held 12,812 shares of Vericel Corp worth $403K as of Q3 2025.
  • Glenmede Investment Management sold 419 Vericel Corp shares in Q3 2025, an estimated $15K.
  • Vericel Corp made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1016 holding.
  • Glenmede Investment Management first reported a position in Vericel Corp in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Vericel Corp position peaked at $563K in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.